This paper is the continuation of our earlier comparative studies concerning the blockade of IKK, NF-κB translocation and of RANKL/RANK interaction as novel therapeutic strategies in the treatment of allergic asthma [6]. This evidence concerns the gene NFKB1 and allergic asthma.